China
Lucentis approved in China
January 18, 2012Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets
Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …
Boehringer expands manufacturing in China
December 15, 2011Manufacturing and Production Boehringer, China, manufacturing
Boehringer Ingelheim plans to invest €50 million in its manufacturing plant in Shanghai as part of a drive to increase …
Bayer forecasts €11 billion growth in Asia
November 17, 2011Bayer, China, emerging markets
Bayer is expecting sales in Asia to grow by €11 billion over the next four years, with over half of …
China’s SFDA starts overseas inspections
November 15, 2011Manufacturing and Production China, SFDA, manufacturing and production
China’s State Food and Drug Administration (SFDA) has started to inspect overseas manufacturing facilities in yet another sign of the …
Bosch planning second packaging plant in China
November 7, 2011Manufacturing and Production Bosch, China
Bosch Packaging Technology has decided to boost its presence in Asia with the construction of a second plant in the …
Lundbeck establishes research centre in China
October 18, 2011Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets
Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …
AstraZeneca plans $200m manufacturing plant in China
October 11, 2011Manufacturing and Production AstraZeneca, China, pharma manufacturing news
AstraZeneca has announced plans to set up a manufacturing facility in north-eastern China, backed by a record investment by the …
Novo Nordisk’s Victoza launched in China
October 10, 2011Sales and Marketing Byetta, China, Victoza, diabetes
Novo Nordisk’s Victoza is now available in China, one of the fastest growing diabetes markets in the world. Victoza (liraglutide …
Betting big on research in China
September 13, 2011Manufacturing and Production, Research and Development China, R&D
For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …
GSK takes control of China vaccines venture
June 15, 2011Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines
GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …
Pfizer signs Chinese commercial collaboration
May 9, 2011Sales and Marketing China, Pfizer, Shanghai Pharmaceutical Co
US giant Pfizer looks set to collaborate with Shanghai Pharmaceutical Co. on business opportunities in China. The potential partnership is …
Anglo-Chinese joint venture makes first API batches
April 26, 2011Manufacturing and Production China, Hebei Aoxing Pharmaceutical, Macfarlan Smith, manufacturing and production
China’s Hebei Aoxing Pharmaceutical has passed a major milestone in its joint venture with process technology specialist Macfarlan Smith to …
China’s new GMP rules will lead to industry consolidation
April 4, 2011Manufacturing and Production China, GMP
China’s new rules on Good Manufacturing Practice is likely to drive consolidation among the country’s 5,000-plus pharmaceutical companies, according to …
Novartis increases stake in Chinese vaccines firm
March 22, 2011Sales and Marketing China, emerging markets, vaccines
Novartis has continued its expansion into developing markets with the acquisition of a majority stake in a Chinese vaccines company. …
Aurobindo sells Chinese API unit to Sinopharm
January 13, 2011Manufacturing and Production API, Aurobindo Pharma, China, Sinopharm Weiqida Pharmaceutical, active pharmaceutical ingredient
Indian company Aurobindo Pharma intends to sell off a loss-making active pharmaceutical ingredient unit to Sinopharm, the largest pharmaceutical company …
